These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11764539

  • 1. Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy.
    Krishnan K, Brenner DE.
    Gastroenterol Clin North Am; 2001 Dec; 30(4):981-1000. PubMed ID: 11764539
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N.
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
    Buskens CJ, Ristimäki A, Offerhaus GJ, Richel DJ, van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2003 Mar; (239):87-93. PubMed ID: 14743889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe?
    Wallace JL, Reuter BK, McKnight W, Bak A.
    J Clin Gastroenterol; 1998 Mar; 27 Suppl 1():S28-34. PubMed ID: 9872495
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
    Meyer-Kirchrath J, Schrör K.
    Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 15. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
    Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ.
    Gastroenterology; 2002 Apr 15; 122(4):1101-12. PubMed ID: 11910360
    [Abstract] [Full Text] [Related]

  • 16. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov 15; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 17. Role of cyclooxygenase inhibitors for the prevention of colorectal cancer.
    Stack E, DuBois RN.
    Gastroenterol Clin North Am; 2001 Dec 15; 30(4):1001-10. PubMed ID: 11764529
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2: a therapeutic target.
    Turini ME, DuBois RN.
    Annu Rev Med; 2002 Dec 15; 53():35-57. PubMed ID: 11818462
    [Abstract] [Full Text] [Related]

  • 19. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA, Dubois RN.
    Nat Rev Cancer; 2001 Oct 15; 1(1):11-21. PubMed ID: 11900248
    [Abstract] [Full Text] [Related]

  • 20. COX-2-Selective NSAIDs: new and improved?
    Lichtenstein DR, Wolfe MM.
    JAMA; 2000 Sep 13; 284(10):1297-9. PubMed ID: 10980759
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.